Please select an option below to help us tailor your newsletter to best suit your content interests!
A Phase 1/2, Open Label, Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors
A Phase 1/2, Open Label, Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors
CURRENTLY ONLY THE MELANOMA COHORT IS ENROLLING
Inclusion Criteria:
Exclusion Criteria:
Primary:
Secondary